ApprovalTrail

Approval · Notice of Compliance 27864 · 2022

ULTRAM: Notice of Compliance 27864

Issued March 31, 2022

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
27864
Date
March 31, 2022
Company
Janssen Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Safety updates to the Product Monograph and updates to the labels as per the Advisement Letter.

Products in this notice

BrandDINStatus today
ULTRAMNot yet assigned—

Medicinal ingredients